BioSpace News Archive

Nuvo Group and Sheba Medical Center’s “Sheba BEYOND” Complete First Phase of Collaboration to Create a Virtual Obstetric Solution

Nuvo Group announced today that it has completed the first phase of its collaboration agreement with Israel’s Sheba Medical Center’s “Sheba BEYOND”, one of the Top Ten medical centers in the world (NEWSWEEK) and a global leader in biotechnological innovation.

August 17, 2022
·
5 min read
BioCapital

Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Provisional Approval in New Zealand as a First and Second Booster for Adults

Nuvaxovid™ is New Zealand’s first and only protein-based COVID-19 vaccine Nuvaxovid™ can now be used as a first or second booster dose for adults aged 18 and older vaccinated with any primary series vaccine.

August 17, 2022
·
12 min read
Biotech Bay

Atomwise Signs Strategic Multi-Target Research Collaboration with Sanofi for AI-Powered Drug Discovery

Atomwise, a leader in using artificial intelligence (AI) for small molecule drug discovery, today announced that it has established a strategic and exclusive research collaboration with Sanofi that will leverage its AtomNet® platform for computational discovery and research of up to five drug targets.

August 17, 2022
·
3 min read
Business

Mytide Therapeutics Partners with Agilent to Collaborate on Automation Solutions for Mytide’s Next-generation Manufacturing Platform

Mytide Therapeutics has partnered with Agilent, a global leader in life science, diagnostic and applied chemical markets.

August 17, 2022
·
4 min read
Genetown

Gelesis to Participate in Fireside Chat with IPO Edge Today at 2:00 PM ET

Gelesis Holdings Inc. today announced that the Company is participating in a fireside chat with IPO Edge today at 2:00 PM ET.

August 17, 2022
·
7 min read
FDA

FDA Clears ImmunoCAP™ Blood Tests for Wheat and Sesame Allergy

Today, Thermo Fisher Scientific announces the clearance of ImmunoCAP Specific IgE (sIgE) Allergen Components for wheat and sesame* allergies by the U.S. Food & Drug Administration (FDA) for in vitro diagnostic use.

August 17, 2022
·
4 min read
BioMidwest

BioDerm, Inc. Readies for Direct-to-Consumer Growth with Executive Additions

BioDerm, Inc., a leading provider of disposable medical devices and wound care supplies, announced the addition of two executives to strengthen its leadership position in providing premium solutions for patients with chronic medical conditions.

August 17, 2022
·
2 min read
Biotech Beach

Ensysce Biosciences Releases Updated Investor Presentation Ahead of Corporate Update Call

Ensysce Biosciences, Inc. today released an updated investor presentation to its investor relations website accessible via https://ir.ensysce.com/

August 17, 2022
·
2 min read
Business

Kriya Appoints Pedro Huertas M.D., Ph.D., as Chief Medical Officer of its Rare Disease Division

Kriya Therapeutics, Inc announced today that it has appointed Pedro Huertas, M.D., Ph.D., as Chief Medical Officer of its Rare Disease Division.

August 17, 2022
·
2 min read
Deals

Bristol Myers Squibb Completes Acquisition of Turning Point Therapeutics, Expanding Precision Oncology Portfolio

Bristol Myers Squibb (NYSE:BMY) announced today that it has successfully completed its acquisition of Turning Point Therapeutics, Inc. (“Turning Point”), in an all-cash transaction.

August 17, 2022
·
6 min read